iShares Dow Jones US Medical Dev. shares owned by Ladenburg Thalmann Financial Services
Quarter-by-quarter ownership of iShares Dow Jones US Medical Dev. (IHI) shares owned by Ladenburg Thalmann Financial Services
from 13F filings
Historical chart of Ladenburg Thalmann Financial Services investment in iShares Dow Jones US Medical Dev.
Tip: Access up to 7 years of quarterly data
All positions including iShares Dow Jones US Medical Dev. held by Ladenburg Thalmann Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in iShares Dow Jones US Medical Dev. by Ladenburg Thalmann Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2019-12-31 | $17M | 64k | 264.32 |
| 2019-09-30 | $18M | 72k | 247.23 |
| 2019-06-30 | $15M | 63k | 240.72 |
| 2019-03-31 | $16M | 67k | 231.52 |
| 2018-12-31 | $12M | 62k | 199.82 |
| 2018-09-30 | $16M | 69k | 227.47 |
| 2018-06-30 | $11M | 58k | 185.01 |
| 2018-03-31 | $11M | 58k | 185.01 |
| 2017-12-31 | $7.8M | 45k | 173.51 |
| 2017-09-30 | $6.7M | 40k | 167.04 |
| 2017-06-30 | $8.1M | 45k | 178.57 |
| 2017-03-31 | $4.3M | 28k | 151.41 |
| 2016-12-31 | $4.1M | 31k | 133.14 |
| 2016-09-30 | $1.4M | 9.7k | 145.36 |
| 2016-06-30 | $977k | 7.2k | 135.59 |
| 2016-03-31 | $617k | 5.0k | 122.48 |
| 2015-12-31 | $652k | 5.3k | 122.47 |
| 2015-09-30 | $465k | 4.2k | 111.19 |
| 2015-06-30 | $590k | 4.9k | 119.83 |
| 2015-03-31 | $241k | 2.0k | 120.51 |
| 2014-12-31 | $194k | 1.7k | 112.92 |
| 2014-09-30 | $131k | 1.3k | 99.39 |
| 2014-06-30 | $134k | 1.3k | 101.67 |
| 2014-03-31 | $130k | 1.3k | 98.63 |
| 2013-12-31 | $113k | 1.2k | 92.78 |
| 2013-09-30 | $145k | 1.7k | 84.40 |
| 2013-06-30 | $77k | 980 | 78.57 |
| 2011-12-31 | $40k | 682 | 58.65 |
More positions owned by Ladenburg Thalmann Financial Services
View all positions for Ladenburg Thalmann Financial Services
Top funds holding iShares Dow Jones US Medical Dev.
View all funds holding iShares Dow Jones US Medical Dev.